Protein kinase C ζ regulates survivin expression and inhibits apoptosis in colon cancer

被引:9
作者
Umemori, Yoshifumi [1 ]
Kuribayashi, Kageaki [1 ]
Nirasawa, Shinya [1 ]
Kondoh, Takashi [1 ]
Tanaka, Maki [1 ]
Kobayashi, Daisuke [1 ]
Watanabe, Naoki [1 ]
机构
[1] Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
关键词
PKC zeta; survivin; apoptosis; TRAIL; colon cancer; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; BREAST-CANCER; PI; 3-KINASE; IN-VITRO; PATHWAY; CELLS; DEATH; MUTATIONS; ALPHA;
D O I
10.3892/ijo.2014.2489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The phosphatidylinositol 3-kinase pathway transduces cell survival signals in different malignancies. Protein kinase C zeta (PKC zeta) is one of the molecules involved in this pathway. In this study, we investigated the role of PKC zeta in apoptosis. Short interfering RNA against PKC zeta (siPKC zeta) sensitized HCT116 and SW480 colon cancer cells to TRAIL-induced apoptosis. Among anti-apoptotic proteins, survivin protein and mRNA expression levels decreased after siPKC zeta transfection while protein half-life did not change. The expression levels of survivin and PKC zeta were correlated in 18 colon cancer specimens (r=0.72, P=3.01x10(-4)). Chemosensitivity to 5-FU was enhanced by siPKC zeta in HCT116 and SW480 cells. These results indicate that PKC zeta regulates survivin expression levels and inhibits apoptosis in colon cancer cells. This study provides a rationale for targeting PKC zeta in combination with chemotherapy for colon cancer treatment.
引用
收藏
页码:1043 / 1050
页数:8
相关论文
共 45 条
[1]   TRAIL receptor signaling and therapeutics [J].
Abdulghani, Junaid ;
El-Deiry, Wafik S. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (10) :1091-1108
[2]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[3]   Opinion - Survivin, cancer networks and pathway-directed drug discovery [J].
Altieri, Dario C. .
NATURE REVIEWS CANCER, 2008, 8 (01) :61-70
[4]   A role for survivin in radioresistance of pancreatic cancer cells [J].
Asanuma, K ;
Kobayashi, D ;
Furuya, D ;
Tsuji, N ;
Yagihashi, A ;
Watanabe, N .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (09) :1057-1062
[5]   Role of RAS in the Regulation of PI 3-Kinase [J].
Castellano, Esther ;
Downward, Julian .
PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 :143-169
[6]   Regulation of mitochondrial Smac/DIABLO-selective release by survivin [J].
Ceballos-Cancino, G. ;
Espinosa, M. ;
Maldonado, V. ;
Melendez-Zajgla, J. .
ONCOGENE, 2007, 26 (54) :7569-7575
[7]   Mutations of the epidermal growth factor receptor in non-small cell lung cancer - Search and destroy [J].
Chan, SK ;
Gullick, WJ ;
Hill, ME .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (01) :17-23
[8]   Regulation of protein kinase C ζ by PI 3-kinase and PDK-1 [J].
Chou, MM ;
Hou, WM ;
Johnson, J ;
Graham, LK ;
Lee, MH ;
Chen, CS ;
Newton, AC ;
Schaffhausen, BS ;
Toker, A .
CURRENT BIOLOGY, 1998, 8 (19) :1069-1077
[9]   Protein kinase C mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase [J].
Cohen, Ezra Eddy Wyssant ;
Lingen, Mark W. ;
Zhu, Bangmin ;
Zhu, Hongyan ;
Straza, Michael Wayne ;
Pierce, Carolyn ;
Martin, Leslie E. ;
Rosner, Marsha Rich .
CANCER RESEARCH, 2006, 66 (12) :6296-6303
[10]   Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis [J].
Cully, M ;
You, H ;
Levine, AJ ;
Mak, TW .
NATURE REVIEWS CANCER, 2006, 6 (03) :184-192